Company

"ANT Neuro is a Dutch corporation specialized in the development, marketing and sales of medical and research applications. ANT Neuro was established in 1997,as a spin-off company of the University of Twente, Enschede. It now has offices located in Hengelo, The Netherlands; Berlin, Germany; London, UK; Philadelphia, USA; and Hong Kong, China.

ANT Neuro specializes in being a single-source provider of high performance products within neuroscience research and neurodiagnostics. Applications include EEG, EMG, MRI, TMS and MEG technology.

Using ANT Neuro products, functional brain information is fused with anatomical scans to gain insight into the working mechanisms of cognition and a variety of brain disorders. Our technology offers a wide range of applications in cognitive neuroscience, neurology and psychiatry."

Company

Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States.

Neuromodulation is the second-oldest and third-largest department of Medtronic. Its products include neurostimulation systems and implantable drug delivery systems for chronic pain, common movement disorders, and urologic and gastrointestinal disorders. The department's revenues in 2014 amounted to $1.9 billion, or 11% of Medtronic's total revenues.

Company

"The RNS System is an award-winning technology developed and manufactured in Silicon Valley that has been recognized for its innovation. Similar to a pacemaker that monitors and responds to heart rhythms, the RNS System is the world's first and only medical device that can monitor and respond to brain activity.



NeuroPace was founded to design, develop, manufacture and market implantable devices for the treatment of neurological disorders with responsive stimulation. The company's initial focus is the treatment of epilepsy, a debilitating neurological disorder affecting approximately 1% of the population worldwide.In addition to treating epilepsy, responsive neurostimulation holds the promise of treating several other disabling medical disorders that impact the quality of life for millions of patients around the world."

Company

"The collaborative, diverse BrainGate team creates and tests the devices that are ushering in a new era of transformative neurotechnologies. Using an array of micro-electrodes implanted into the brain, our pioneering research has shown that the neural signals associated with the intent to move a limb can be “decoded” by a computer in real-time and used to operate external devices. This investigational system, called BrainGate (Caution: Investigational Device. Limited by federal law to investigational use.) has allowed people with spinal cord injury, brainstem stroke, and ALS to control a computer cursor simply by thinking about the movement of their own paralyzed hand and arm.

In early clinical research, the technology has provided intuitive control over advanced prosthetic limbs, and provided people with paralysis with easy control over powerful assistive movement and communication devices. An exciting goal is to enable naturally-controlled movements of paralyzed limbs. In addition, we are developing a new generation of wireless medical neurotechnologies that will be able to record and monitor neural activity to assist in the diagnosis and management of neurologic disease."

Company

"The last decade has seen amazing progress in neuroscience, enabling researchers to envision a new generation of brain machine interfaces. These systems will be used to treat chronic diseases like Parkinson's, epilepsy, and Alzheimer's. They will restore mobility to the paralyzed and speed recovery from a stroke. They may even allow us to control our mood and enhance our cognition. Rune Labs wants to build the software at the heart of these systems, and help accelerate the next wave of neuromodulation applications."